Kodiak Sciences Inc (NAS:KOD)
$ 3.61 -0.19 (-5%) Market Cap: 189.65 Mil Enterprise Value: -4.24 Mil PE Ratio: 0 PB Ratio: 0.71 GF Score: 41/100

Kodiak Sciences Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 14, 2022 / 08:05PM GMT
Release Date Price: $9.23 (-1.28%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

Great. Well, good afternoon, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. Really pleased to have Kodiak with us. Quickly before we get started, I just need to read a disclosure statement.

So please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures appear on the Morgan Stanley public website at morganstanley.com/researchdisclosures.

So with that, pleased to have Victor Perlroth, who is the CEO of Kodiak with us. Victor, I thought maybe a good place to start is just in the last -- it is the last week.

Questions & Answers

Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

It all blends together, but we got some -- we've got some data from Regeneron on high-dose. I think that just maybe a nice place to start is just how do you think about the competitive market at this point? There's been

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot